SBIR-STTR Award

Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization
Award last edited on: 3/5/2025

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$1,057,959
Award Phase
2
Solicitation Topic Code
859
Principal Investigator
Yuchao Chen

Company Information

Wellsim Biomedical Technologies Inc

200 Lincoln Centre Drive
Foster City, CA 94404
   (814) 777-8586
   N/A
   www.wellsimbiotech.com
Location: Single
Congr. District: 14
County: San Mateo

Phase I

Contract Number: 1R43GM145015-01
Start Date: 3/1/2022    Completed: 2/28/2023
Phase I year
2022
Phase I Amount
$249,974
Exosomes, the small extracellular vesicles (30-200 nm), are highly heterogeneous in biofluids. However, traditional bulk-level analysis approaches fail to represent their individual variations. A technique for multi-omicsprofiling of exosomes at single-particle resolution is of great interest to the exosome research field, but has yetto be developed. WellSIM proposes to develop and validate a method for multi-omics profiling of individualexosomes based on our exosome isolation system (EXODUS), a droplet-based microfluidic device (EXOSeq), and next-generation sequencing (NGS). Our proposed technique will be the first integrative proteomic andtranscriptomic profiling of exosomes at the single-particle level, offering high-resolution multi-dimensionalbiological insights for exosome study and application.

Public Health Relevance Statement:
PROJECT NARRATIVE The conventional exosome characterization approaches usually analyze entire exosome populations, which cannot reveal the exosome heterogeneities or quantify exosome subpopulations in biofluids. Our proposed technique could address the unmet need for multi-omics single-exosome studies, offering substantial benefits to the EV research community. Its unprecedented resolution and sensitivity for exosome interrogation will facilitate exosome-based biomarker discovery and detection. This technique will also enable characterization of exosome subpopulations and their tissues of origin, as well as improve our understanding of exosome biogenesis and biological functions.

Project Terms:

Phase II

Contract Number: 2R44GM145015-02A1
Start Date: 3/1/2022    Completed: 7/31/2026
Phase II year
2024
Phase II Amount
$807,985
Extracellular vesicles (EVs) exhibit high heterogeneity in biofluids, a feature that traditional bulk-level analysis approaches fail to capture in terms of individual variations. While numerous techniques exist for single-EV analysis, the majority focus primarily on profiling surface proteins. Transcriptional analysis at the level of individual EVs, however, remains largely unexplored. To bridge this gap, we propose the development of a technology for multimodal profiling of individual EVs, leveraging next-generation sequencing and an optimized method for multiplex library preparation. This proposed platform will serve as a unique tool for high-throughput, integrative profiling of single-EV gene expression and surface proteins. It aims to offer high-sensitivity, multi- dimensional biological insights, thereby potentially accelerating the advancement of EV-based diagnostics and targeted therapies.

Public Health Relevance Statement:
NARRATIVE Conventional approaches to characterizing extracellular vesicles (EVs) often analyze the entire sample population (bulk analysis), neglecting the inherent EV heterogeneity and failing to quantify EV subpopulations within biofluids. Our proposed technique aims to address these unmet needs by facilitating multimodal studies at the single-EV level, thereby offering significant advantages to the broader EV research community. Its exceptional resolution and sensitivity are poised to accelerate EV-based biomarker discovery and advance the field of precision medicine. Moreover, this innovative method will facilitate the multimodal analysis of low- abundance EV samples, while also serving as an advanced quality control tool for EV-based drug delivery. Terms:
© Copyright 1983-2025  |  Innovation Development Institute, LLC   |  Swampscott, MA  |  All Rights Reserved.